TET2 and adrenal cortex carcinoma: Furthermore, survival analysis indicated that methylation of TET1 was linked to a lower survival rate in ACC and a higher survival rate in UVM; methylation of TET2 was associated with increased survival rates in ACC, KIRP, and PCPG; while methylation of TET3 correlated with decreased survival rates in SARC and BLCA (Figure 3C, Supplementary Table S2).